Determination of logP coefficients via a RP-HPLC column
AssigneePfizer Inc.
InventorsFranco Lombardo, Marina Y. Shalaeva, Karl A. Tupper
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsFranco Lombardo, Marina Y. Shalaeva, Karl A. Tupper
Estimating the term…
This invention provides a RP-HPLC method, for the determination of logPoct values, which combines ease of operation and high accuracy, and which has been shown to work for a set of 36 molecules largely comprised of drugs. The general features of the method are: i) compound sparing (≦1 mL of a 30-50 μg/mL solution needed), ii) rapid determinations (20 minutes on average), iii) low sensitivity to impurities, iv) wide lipophilicity range (6 logPoct units), v) good accuracy, vi) excellent reproducibility. A linear free energy relationship (LFER) analysis, based on solvation parameters, shows that the method encodes the same information obtained from a shake-flask logPoct determination. The value generated via this method is referred to as ElogPoct.
A method of determining ElogPoct for chemical compounds which comprises:
A method of determining ElogPoct for chemical compounds which comprises:
A method of determining ElogPoct for chemical compounds which comprises:
Dependencies are inferred from the claim text.